Exercise Training for Obesity-Related Endothelial Dysfunction

Microvascular Dysfunction in Obesity

Recruiting N/A Interventional Study
Obesity Endothelial Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
25 (estimated)
Sponsor
Florida State University · Other
Who this trial is looking for

This trial is looking for premenopausal women who are sedentary and have obesity-related health issues. Participants will engage in an 8-week aerobic exercise program while researchers monitor their body’s response to exercise.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a premenopausal woman.
  • I have been diagnosed with obesity and Metabolic Syndrome.
  • I have been weight stable for the last 6 months.
  • I am on combined estrogen/progestin hormonal contraceptive therapy.

You may not be able to join if

  • I smoke or chew tobacco.
  • I have diabetes with fasting blood glucose over 125 mg/dL.
  • I have high blood pressure over 160/95 mmHg.
  • I have heart disease or serious heart problems.
  • I have had any serious orthopedic problems affecting exercise.
  • I am taking medications that affect circulation.
  • I have gained or lost more than 5% of my weight during the program.
  • I have not completed at least 90% of the exercise sessions.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Impaired endothelial function is observed in disease states related to obesity, such as atherosclerosis, coronary artery disease, and diabetes. Reactive oxygen species (ROS) production and resultant oxidative stress contribute to the development of these obesity-related diseases. The enzyme NADPH-oxidase is a major source of oxidative stress within the vasculature, and has been linked with the Met…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * There will be no restrictions with regard to race, sex, or socioeconomic status. * Women will be premenopausal * Women will be on combined estrogen/progestin hormonal contraceptive therapy (oral pill, transdermal patch or vaginal ring). * Sedentary obese individuals will have …
Contacts

Robert C Hickner, PhD

850-644-1375

rhickner@fsu.edu

CONTACT